Business Description
Mira Pharmaceuticals Inc
NAICS : 325412
SIC : 2834
ISIN : US60458C1045
Compare
Compare
Traded in other countries / regions
MIRA.USAK6S.Germany IPO Date
2023-08-03Description
Mira Pharmaceuticals Inc is a pre-clinical-stage pharmaceutical development company with two neuroscience programs targeting a broad range of neurologic and neuropsychiatric disorders. The company's novel oral pharmaceutical marijuana, MIRA-55, is under investigation for treating adult patients suffering from anxiety and cognitive decline, often associated with early-stage dementia.
Financial Strength
8/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 3529 | |||||
Equity-to-Asset | 0.83 | |||||
Piotroski F-Score | N/A/9 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Future 3-5Y EPS without NRI Growth Rate | 17.5 |
Momentum Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 62.22 | |||||
9-Day RSI | 63.21 | |||||
14-Day RSI | 63.47 | |||||
6-1 Month Momentum % | -35.32 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 5.7 | |||||
Quick Ratio | 5.7 | |||||
Cash Ratio | 5.41 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Shareholder Yield % | -0.19 |
Profitability Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
ROE % | -410.49 | |||||
ROA % | -281.12 | |||||
ROIC % | -502.07 | |||||
ROC (Joel Greenblatt) % | -11220.55 | |||||
ROCE % | -294.38 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PB Ratio | 12.9 | |||||
Price-to-Tangible-Book | 12.9 | |||||
EV-to-EBIT | -4.62 | |||||
EV-to-EBITDA | -4.62 | |||||
EV-to-FCF | -9.19 | |||||
Price-to-Net-Current-Asset-Value | 12.9 | |||||
Price-to-Net-Cash | 14.26 | |||||
Earnings Yield (Greenblatt) % | -21.65 | |||||
FCF Yield % | -11.25 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:MIRA
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Mira Pharmaceuticals Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil $) | |||
EPS (TTM) ($) | -0.858 | ||
Beta | 0 | ||
Volatility % | 0 | ||
14-Day RSI | 63.47 | ||
14-Day ATR ($) | 0.660601 | ||
20-Day SMA ($) | 1.164355 | ||
12-1 Month Momentum % | 0 | ||
52-Week Range ($) | 0.51 - 7.9799 | ||
Shares Outstanding (Mil) | 14.78 |
Piotroski F-Score Details
Year:
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 9999 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Mira Pharmaceuticals Inc Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Mira Pharmaceuticals Inc Stock Events
Event | Date | Price($) | ||
---|---|---|---|---|
No Event Data |
Mira Pharmaceuticals Inc Frequently Asked Questions
What is Mira Pharmaceuticals Inc(MIRA)'s stock price today?
The current price of MIRA is $2.70. The 52 week high of MIRA is $7.98 and 52 week low is $0.51.
When is next earnings date of Mira Pharmaceuticals Inc(MIRA)?
The next earnings date of Mira Pharmaceuticals Inc(MIRA) is 2024-09-13 Est..
Does Mira Pharmaceuticals Inc(MIRA) pay dividends? If so, how much?
Mira Pharmaceuticals Inc(MIRA) does not pay dividend.
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |